Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in the liver cells: a new clinicopathologic entity with report of 12 cases. Medicine. 1954;33:155-197.
Haimi-Cohen Y, Merlob P, Marcus-Eidlits T, et al. Dubin-Johnson syndrome as a cause of neonatal jaundice: the importance of coproporphyrins investigation. Clin Pediatr (Phil). 1998;37:511-513.
Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology. 1997;25:1539-1542.
Frank M, Doss M, de Carvalho DG. Diagnostic and pathogenetic implications of urinary coproporphyrin excretion in Dubin-Johnson syndrome. Hepatogastroenterology. 1990;37:147-151.
Machida I, Wakusawa S, Sanae F, et al. Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan. J Gastroenterol. 2005;40:366-370.
1. Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in the liver cells: a new clinicopathologic entity with report of 12 cases. Medicine. 1954;33:155-197.
2. Sprinz H, Nelson RS. Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of 4 cases. Ann Intern Med. 1954;41:952-962.
3. Dubin IN. Chronic idiopathic jaundice: a review of 50 cases. Am J Med. 1958;24:268-292.
4. Javitt NB, Kondo T, Kuchiba K. Bile acid secretion in Dubin-Johnson syndrome. Gastroenterology. 1978;75:931-932.
5. Rastogi A, Krishnani N, Pandey R. Dubin-Johnson syndrome: a clinicopathologic study of twenty cases. Indian J Pathol Microbiol. 2006;49:500-504.
6. Seligsohn U, Shani M. The Dubin-Johnson syndrome and pregnancy. Acta Hepatogastroenterol. 1977;24:167-169.
7. Di Zoglio JD, Cardillo E. The Dubin-Johnson syndrome and pregnancy. Obstet Gynecol. 1973;42:560.
8. Skornick YG, Klausner JM, Lelcuk S, et al. Cholelithiasis in Dubin-Johnson syndrome. Surg Gynecol Obstet. 1983;157:447-449.
9. Sotelo-Avila C, Danis RK, Krafcik J, et al. Cholecystitis in a 17-year-old boy with recurrent jaundice since childhood. J Pediatr. 1988;112:668-674.
10. Kondo T, Yagi R. Dubin-Johnson syndrome in a neonate. N Engl J Med. 1975;292:1028-1029.
11. Nakata F, Oyanagi K, Fujiwara M, et al. Dubin-Johnson syndrome in a neonate. Eur J Paediatr. 1979;132:299-301.
12. Haimi-Cohen Y, Merlob P, Marcus-Eidlits T, et al. Dubin-Johnson syndrome as a cause of neonatal jaundice: the importance of coproporphyrins investigation. Clin Pediatr (Phil). 1998;37:511-513.
13. Tsai WH, Teng RJ, Chu JS, et al. Neonatal Dubin-Johnson syndrome. J Paediatr Gastroenterol Nutr. 1994;18:253-254.
14. Shani M, Seligsohn V, Gilon E, et al. Dubin-Johnson syndrome in Israel: clinical, laboratory and genetic aspects of 101 cases. Q J Med. 1970;39:549-567.
15. Zlotogora J. Hereditary disorders among Iranian Jews. Am J Med Genet. 1995;58:32-37.
16. Mor-Cohen R, Zivelin A, Fromovich-Amit Y, et al. Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations. Blood Coagul Fibrinolysis. 2007;18:139-144.
17. Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology. 1997;25:1539-1542.
18. Toh S, Wada M, Uchiumi T, et al. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/CMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet. 1999;64:739-746.
19. Van Kuijck MA, Kool M, Merkx GF, et al. Assignment of the canalicular multispecific organic anion transporter gene (CMOAT) to human chromosome 10q24 and mouse chromosome 19d2 by fluorescent in situ hybridization. Cytogenet Cell Genet. 1997;77:285-287.
20. Mor-Cohen R, Zivelin A, Rosenberg N, et al. A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients. Hepatology Res. 2005;31:104-111.
21. Kartenbeck J, Leuschner U, Mayer R, et al. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology. 1996;23:1061-1066.
22. Jedlitschky G, Hoffmann U, Kroemer HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol. 2006:2:351-366.
23. Varma RR, Grainger JM, Scheuer PJ. A case of Dubin-Johnson syndrome complicated by acute hepatitis. Gut. 1970;11:817.
24. Hunter FM, Sparks RD, Flinner RI. Hepatitis with resulting mobilization of hepatic pigment in a patient with Dubin-Johnson syndrome. Gastroenterology. 1964;47:631-635.
25. Ware AJ, Eigenbrodtt EH, Naftalis J, et al. Dubin Johnson syndrome and viral hepatitis. Gastroenterology. 1974;67:560.
26. Ware AJ, Eigenbrodtt EH, Shorey J. Viral hepatitis complicating the Dubin-Johnson syndrome. Gastroenterology. 1972;63:337.
27. Bar-Meir S, Baron J, Seligson U, et al. 99mTc-HIDA cholescintigraphy rotor in Dubin-Johnson syndromes. Radiology. 1982;142:743-746.
28. The familial conjugated hyperbilirubinemias. Semin Liver Dis. 1994;14:386-394.
29. Frank M, Doss M, de Carvalho DG. Diagnostic and pathogenetic implications of urinary coproporphyrin excretion in Dubin-Johnson syndrome. Hepatogastroenterology. 1990;37:147-151.
30. Rocchi E, Balli F, Gibertini P, et al. Coproporphyrin excretion in healthy newborn babies. J Pediatr Gastroenterol Nutr. 1984;3:402-407.
31. Mayatepek E, Lehmann WD. Defective hepatobilary leukotriene elimination in patients with Dubin-Johnson syndrome. Clin Chim Acta. 1996;249:37-46.
32. Summerfield JA, Scott J, Berman M, et al. Benign recurrent intrahepatic cholestasis: studies of bilirubin kinetics, bile acids, and cholangiography. Gut. 1980;21:150-164.
33. Wareham NJ, Dickson CJ, Baskerville PA. Benign recurrent intrahepatic cholestasis. J R Soc Med. 1985;78:955-966.
34. Machida I, Wakusawa S, Sanae F, et al. Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan. J Gastroenterol. 2005;40:366-370.
35. Lindberg MC. Hepatobiliary complications of oral contraceptives. J Gen Intern Med. 1992;7:199-209.
36. Cohen L, Lewis C, Arias IM. Pregnancy, oral contraceptives and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson syndrome). Gastroenterology. 1972;62:1182-1190.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台